Stay updated on Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial

Sign up to get notified when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T13:35:14.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of terms related to drug safety and counterfeit drugs. Notably, the previous version's references to certain drug names and conditions have been removed.
    Difference
    7%
    Check dated 2025-08-31T11:28:47.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:33:17.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T20:10:40.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated to include new information about a clinical study on the effects of nintedanib on biomarkers in patients with idiopathic pulmonary fibrosis, including details about the study's design, eligibility criteria, and locations. Additionally, it now features a disclaimer regarding the U.S. government's review of studies listed on the site.
    Difference
    100%
    Check dated 2025-08-02T15:25:30.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The webpage has removed significant content related to a clinical study on nintedanib for idiopathic pulmonary fibrosis, including details about the study's purpose, eligibility criteria, and locations. Additionally, a server error message has been added, indicating temporary unavailability of the site.
    Difference
    100%
    Check dated 2025-07-26T12:48:58.000Z thumbnail image

Stay in the know with updates to Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.